Group F-3 ‰»Šw\‘’@(Chemical Structure)  

œ Flavophospholipol @(Flavomycin; Banbermycins)
@@
CASF11015-37-5@@Agriculture MW:
CA CHL/IU Max ( 2.0 mg/ml)  (No data for +S9)
 
1)
1) Sofuni T. (Ed.): Data Book of Chromosomal Aberration Test In Vitro, LIC, Tokyo (1998) (Tables in English)

œ Floxuridine
@@
50-91-9 @Medicine @246.21
HMA Sal/G46 Max ( 2 mg/kg, , mice)
 
1)
MB Phage/PBS2 Min ( 5 ƒΚg/ml)
›
2)
CA Human LY Min ( 0.5 mg/ml)
›
3)
SM CHO/6TG Min ( 0.2ƒΚg/ml)
›
4)
CT C3H 10T1/2 Min ( 10-7 M)
›
5)
1) Gabidge MG & Legator MS: Proc. Soc. Exp., Med., 130, 831- (1969)
2) Smith RH* Mutation Res., 20, 276 (1973)
3) Stopik D: Humangenetik, 14, 24-32 (1971)
4) Aebersold PM: Cancer Res., 39, 808-810 (1979)
5) Jones PA, et al,: Cancer Res., 36, 101-107 (1976)
œ Fluazifop-butyl @(Onecide)
@@@69806-50-4 @Pesticide @ 383
REC B. subtilis Max (?)
 
1)
AM Sal Max (?)
 
1)
CA ? Min (?)
›
1)
DLv Mice Max (?)
 
1)
1) Ishihara Sangyo Co. Ltd.: J. Pesticide Sci., 15, 305-310 (1990) (in Japanese)

œFluometuron
@@@2164-17-2 @Pesticide@ 232.21
AM Sal/G46 Min ( 100 ƒΚg/plate, -S9)
›
1)
AM Sal/TA1535 Max ( 100 ƒΚg/plate, +S9)
 
2)
YM S.serevisiae Max ( 0.125 mg/ml, -S9), 24, 48h@(No data for +S9)
 
3)
1) Seiler JP: Mutation Res., 48, 225-236 (1977)
2)
Seiler JP: Mutation Res., 58, 353 (1978)
3) Siebert D & Lemperle E: Mutation Res., 22, 111-120 (1974)

œ Fluoranthene @(Benzo[jk]fluorene)
@@
206-44-0 @Laboratory @@ 202.26@
CT Rat/embryo Min ( 50 ƒΚg/ml, -S9)
›
1)
1) Freeman AE, et al,: J. Natl. Cancer Inst., 51, 799 (1973)

œ Fluorene
@
@@86-73-7 @@Laboratory@ @ 166.21
AM Sal Max ( 1 mg/plate, }S9)
 
1)
MLA L5178Y Max ( 30 ƒΚg/plate, }S9)   2)
1) McCann J, et al,: Proc. Natl. Acad. Sci.(USA), 72, 5135-5139 (1975)
2) Oberly TJ., et al., Mutation Res., 125, 291-306 (1984)
œ Fluorescent brightner 24 @(Kayaphor SN)
@@
12224-02-1@ Industry/dye @ 1169.06
AM Sal Max ( ?)
 
1)
CA CHL/IU Max ( 2.0 mg/ml, -S9), 24, 48h@(No data for +S9)
 
2)
1) Natl. Inst. Hygien. Sci., Tokyo (?)
2) Sofuni T. (Ed.): Data Book of Chromosomal Aberration Test in vitro LIC, Tokyo (1998) (Tables in English)

œ Fluorescent brightner 225@(Kayaphor LSK)
@@
@@@@@@ Industry/dye @ 952.97
AM Sal Max ( ?)
 
1)
CA CHL/IU Max ( 0.125 mg/ml, -S9), 24, 48h@(No data for +S9)
 
2)
1) Natl. Inst. Hygien. Sci., Tokyo (?)
2) Sofuni T. (Ed.): Data Book of Chromosomal Aberration Test In Vitro LIC, Tokyo (1998) (Tables in English)

œ Fluorescent brightner 260 @(Whitex SA)

@@
@16090-02-1@@@@@ Industry/dye @ 924.92
AM Sal Max ( ?)
 
1)
CA CHL/IU Max ( 0.03 mg/ml, -S9), 24, 48h@(No data for +S9)
 
2)
1) Natl. Inst. Hygien. Sci., Tokyo (?)
2) Sofuni T. (Ed.): Data Book of Chromosomal Aberration Test In Vitro LIC, Tokyo (1998) (Tables in English)

œ 5-Fluorouracil @(5-FU)
@@@51-21-8@Medicine @ 130.08
AM Sal Min (?)
›
1)
MB C. reinhardi
(ƒNƒ‰ƒ~ƒhƒmƒ}ƒXj
Min (?)
›
2)
CA CHL/IU Min ( 0.003 mg/ml, -S9), 24, 48h (No data for +S9)
›
3)
CT C3H 10T1/2 Min ( 10-5 M -S9)
›
4)
MNv Mice/ICR Min ( 15 mg/kg, ip)
›
5)
1) Zeiger E, et al,: Environ. Mol. Mutagen., 19, (suppl 21), 2-141 (1992)
2)
Lawrence CW & Davies DR: Mutation Res., 4, 137 (1967)
3) Ishidate MJr.(Ed.): Data Book, Chromosomal Aberration Test In Vitro, LIS/Japan, Elsvier/Amsterdam (1988)
4) Jones PA, et al,: Cancer Res., 36, 101-107 (1976)
5) Matter P & Schmid W: Mutation Res., 40, 325-338 (1976)


yNotez (Cited from IARC Monographs, Suppl.., 6 (1987)
@@Neither CAs (in two patients) nor SCEs (in three patients) were induced following administration of 5-FU.
@@5-FU induced MNs but not specific locus mutations in mice treated in vivo. It induced aneuploidy, Cas and SCEs in cultured Chinese hamster cells. It did not induce SLRL mutations in Drosophila, but caused genetic crossing-over in fungi. Studies on mutation in bacteria wee inconclusive@(IARC Monographs, 26, 217)
œTop Page@iƒgƒbƒvƒy[ƒWj
œAbbreviation @iΘ—ͺ‹L†j@
œMutagenicity @i•ΟˆΩŒ΄«j
œTest Systems@(ŽŽŒ±–@‚ΜŽν—ށj
œTechnical Problems@i‹Zp“I–β‘θ“_j
œList of@Compoundsi‰»‡•¨ƒŠƒXƒgj
œEvaluation of Results@iŽŽŒ±Œ‹‰Κ‚Μ•]‰Ώj